GHK-Cu for Longevity and Anti-Aging: Protocol, Dosing, and What to Expect
Evidence strength: moderate
What this protocol is for
GHK-Cu for longevity tracks one of the more elegant biological cases in the peptide space. The tripeptide naturally declines steeply with age (estimates suggest plasma levels drop 60 to 70 percent by the seventh decade) and its endogenous functions overlap heavily with the cellular processes that degrade in aging: collagen synthesis, anti-inflammatory signaling, antioxidant defence, gene expression modulation, wound healing capacity. Restoring GHK-Cu toward younger plasma levels is a mechanism-driven longevity hypothesis with strong supporting biology, though longevity-specific trials are absent.
The clinical pattern in user reports tracks the mechanism. Skin quality improvements (the most visible marker) over 12 to 16 weeks. Faster recovery from minor injuries and skin damage. Hair density support as a downstream effect. Anecdotally, users running long-cycle GHK-Cu report subjective gains in skin elasticity, wound-healing speed, and general resilience that align with what the literature predicts for restored plasma GHK-Cu.
Used by many in the recovery / biohacking space as one layer in a multi-pronged longevity stack rather than a standalone protocol. The mechanism addresses the slow-degradation pattern of aging tissue rather than dramatic single-system effects. Run this as a tactical, legal performance layer with realistic expectations: cumulative across cycles, visible over months not weeks. For the longevity case specifically, subcutaneous dosing matters more than topical (which addresses only skin and scalp).
Dose for longevity and anti-aging
1 to 2 mg subcutaneous daily for systemic longevity use. Abdominal subcutaneous is the standard route. Some longevity practitioners run 1 mg per day continuously rather than cycling; the conservative default in the recovery / biohacking community is cycling. Topical use addresses skin and scalp only, not systemic.
Cycle length
8 to 12 weeks on, 4 to 6 weeks off, 2 to 3 cycles per year. Some users run continuous low-dose protocols; the clinical evidence does not strongly support cycled versus continuous for longevity specifically. Cycling is the cost-conservative and conservative-default approach.
Stack pairings
Commonly stacked with NAD+ (oral supplement).
Expected timeline
Week 2–4: skin quality improvements become noticeable (smoother texture, better hydration, faster healing of small abrasions). Week 4–8: cumulative skin and connective-tissue resilience builds. Hair density may also improve as a secondary effect. Week 8–12: deeper systemic effects on collagen turnover and inflammatory baseline land. Long-term (multi-cycle, 12 to 24 months): cumulative anti-aging tissue effects build slowly.
Common mistakes
- Expecting dramatic single-cycle effects. GHK-Cu addresses slow-degradation aging biology; the visible changes are cumulative across cycles, not single-cycle.
- Running topical and expecting systemic longevity benefit. Topical addresses skin and scalp; for the systemic longevity case, subcutaneous is required.
- Treating GHK-Cu as a standalone anti-aging protocol. The longevity case for any single peptide is one slice of healthy aging. Pair with sleep, exercise, nutrition, and other longevity layers as appropriate.
- Inconsistent cycling. The protocol delivers cumulative benefit only if the cycles run consistently over years. Sporadic use does not build the long-term tissue effects the mechanism is designed for.